Potential of Erythrocyte Membrane Lipid Profile as a Novel Inflammatory Biomarker to Distinguish Metabolically Healthy Obesity in Children

Metabolically healthy obesity (MHO) has been described as BMI ≥ 30 kg/m<sup>2</sup>, without metabolic disorders traditionally associated with obesity. Beyond this definition, a standardized criterion, for adults and children, has not been established yet to explain the absence of those...

Full description

Bibliographic Details
Main Authors: Iker Jauregibeitia, Kevin Portune, Itxaso Rica, Itziar Tueros, Olaia Velasco, Gema Grau, Luis Castaño, Federica Di Nolfo, Carla Ferreri, Sara Arranz
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/11/5/337
id doaj-34bfacbaaba347c39cad3482b0b70883
record_format Article
spelling doaj-34bfacbaaba347c39cad3482b0b708832021-04-23T23:05:50ZengMDPI AGJournal of Personalized Medicine2075-44262021-04-011133733710.3390/jpm11050337Potential of Erythrocyte Membrane Lipid Profile as a Novel Inflammatory Biomarker to Distinguish Metabolically Healthy Obesity in ChildrenIker Jauregibeitia0Kevin Portune1Itxaso Rica2Itziar Tueros3Olaia Velasco4Gema Grau5Luis Castaño6Federica Di Nolfo7Carla Ferreri8Sara Arranz9AZTI, Food Research, Basque Research and Technology Alliance (BRTA), Parque Tecnológico de Bizkaia, Astondo Bidea, Edificio 609, 48160 Derio, SpainAZTI, Food Research, Basque Research and Technology Alliance (BRTA), Parque Tecnológico de Bizkaia, Astondo Bidea, Edificio 609, 48160 Derio, SpainBiocruces Bizkaia Health Research Institute, Cruces University Hospital, CIBERDEM/CIBERER, UPV/EHU, Endo-ERN, 48903 Barakaldo, SpainAZTI, Food Research, Basque Research and Technology Alliance (BRTA), Parque Tecnológico de Bizkaia, Astondo Bidea, Edificio 609, 48160 Derio, SpainBiocruces Bizkaia Health Research Institute, Cruces University Hospital, CIBERDEM/CIBERER, UPV/EHU, Endo-ERN, 48903 Barakaldo, SpainBiocruces Bizkaia Health Research Institute, Cruces University Hospital, CIBERDEM/CIBERER, UPV/EHU, Endo-ERN, 48903 Barakaldo, SpainBiocruces Bizkaia Health Research Institute, Cruces University Hospital, CIBERDEM/CIBERER, UPV/EHU, Endo-ERN, 48903 Barakaldo, SpainLipidomic Laboratory, Lipinutragen srl, Via di Corticella 181/4, 40128 Bologna, ItalyConsiglio Nazionale delle Ricerche, ISOF, Via Piero Gobetti 101, 40129 Bologna, ItalyAZTI, Food Research, Basque Research and Technology Alliance (BRTA), Parque Tecnológico de Bizkaia, Astondo Bidea, Edificio 609, 48160 Derio, SpainMetabolically healthy obesity (MHO) has been described as BMI ≥ 30 kg/m<sup>2</sup>, without metabolic disorders traditionally associated with obesity. Beyond this definition, a standardized criterion, for adults and children, has not been established yet to explain the absence of those metabolic disorders. In this context, biomarkers of inflammation have been proposed as suitable candidates to describe MHO. The use of mature red blood cell fatty acid (RBC FA) profile is here proposed since its membrane lipidome includes biomarkers of pro- and anti-inflammatory conditions with a strict relationship with metabolic and nutritional status. An observational study was carried out in 194 children (76 children with obesity and 118 children with normal weight) between 6 and 16 years old. RBC FAs were analyzed by gas chromatography-flame ionization detector (GC-FID). An unsupervised hierarchical clustering method was conducted on children with obesity, based on the RBC FA profile, to isolate the MHO cluster. The MHO cluster showed FA levels similar to children with normal weight, characterized by lower values of arachidonic acid, total ω-6 FA, ω6/ω3 FA ratios and higher values for EPA, DHA, and total ω-3 FA) (for all of them <i>p</i> ≤ 0.01) compared to the rest of the children with obesity (obese cluster). The MHO cluster also presented lipid indexes for higher desaturase enzymatic activity and lower SFA/MUFA ratio compared to the obese cluster. These differences are relevant for the follow-up of patients, also in view of personalized protocols providing tailored nutritional recommendations for the essential fatty acid intakes.https://www.mdpi.com/2075-4426/11/5/337children, inflammation, lipidomics, mature erythrocyte membrane, metabolically healthy obesity.
collection DOAJ
language English
format Article
sources DOAJ
author Iker Jauregibeitia
Kevin Portune
Itxaso Rica
Itziar Tueros
Olaia Velasco
Gema Grau
Luis Castaño
Federica Di Nolfo
Carla Ferreri
Sara Arranz
spellingShingle Iker Jauregibeitia
Kevin Portune
Itxaso Rica
Itziar Tueros
Olaia Velasco
Gema Grau
Luis Castaño
Federica Di Nolfo
Carla Ferreri
Sara Arranz
Potential of Erythrocyte Membrane Lipid Profile as a Novel Inflammatory Biomarker to Distinguish Metabolically Healthy Obesity in Children
Journal of Personalized Medicine
children, inflammation, lipidomics, mature erythrocyte membrane, metabolically healthy obesity.
author_facet Iker Jauregibeitia
Kevin Portune
Itxaso Rica
Itziar Tueros
Olaia Velasco
Gema Grau
Luis Castaño
Federica Di Nolfo
Carla Ferreri
Sara Arranz
author_sort Iker Jauregibeitia
title Potential of Erythrocyte Membrane Lipid Profile as a Novel Inflammatory Biomarker to Distinguish Metabolically Healthy Obesity in Children
title_short Potential of Erythrocyte Membrane Lipid Profile as a Novel Inflammatory Biomarker to Distinguish Metabolically Healthy Obesity in Children
title_full Potential of Erythrocyte Membrane Lipid Profile as a Novel Inflammatory Biomarker to Distinguish Metabolically Healthy Obesity in Children
title_fullStr Potential of Erythrocyte Membrane Lipid Profile as a Novel Inflammatory Biomarker to Distinguish Metabolically Healthy Obesity in Children
title_full_unstemmed Potential of Erythrocyte Membrane Lipid Profile as a Novel Inflammatory Biomarker to Distinguish Metabolically Healthy Obesity in Children
title_sort potential of erythrocyte membrane lipid profile as a novel inflammatory biomarker to distinguish metabolically healthy obesity in children
publisher MDPI AG
series Journal of Personalized Medicine
issn 2075-4426
publishDate 2021-04-01
description Metabolically healthy obesity (MHO) has been described as BMI ≥ 30 kg/m<sup>2</sup>, without metabolic disorders traditionally associated with obesity. Beyond this definition, a standardized criterion, for adults and children, has not been established yet to explain the absence of those metabolic disorders. In this context, biomarkers of inflammation have been proposed as suitable candidates to describe MHO. The use of mature red blood cell fatty acid (RBC FA) profile is here proposed since its membrane lipidome includes biomarkers of pro- and anti-inflammatory conditions with a strict relationship with metabolic and nutritional status. An observational study was carried out in 194 children (76 children with obesity and 118 children with normal weight) between 6 and 16 years old. RBC FAs were analyzed by gas chromatography-flame ionization detector (GC-FID). An unsupervised hierarchical clustering method was conducted on children with obesity, based on the RBC FA profile, to isolate the MHO cluster. The MHO cluster showed FA levels similar to children with normal weight, characterized by lower values of arachidonic acid, total ω-6 FA, ω6/ω3 FA ratios and higher values for EPA, DHA, and total ω-3 FA) (for all of them <i>p</i> ≤ 0.01) compared to the rest of the children with obesity (obese cluster). The MHO cluster also presented lipid indexes for higher desaturase enzymatic activity and lower SFA/MUFA ratio compared to the obese cluster. These differences are relevant for the follow-up of patients, also in view of personalized protocols providing tailored nutritional recommendations for the essential fatty acid intakes.
topic children, inflammation, lipidomics, mature erythrocyte membrane, metabolically healthy obesity.
url https://www.mdpi.com/2075-4426/11/5/337
work_keys_str_mv AT ikerjauregibeitia potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
AT kevinportune potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
AT itxasorica potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
AT itziartueros potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
AT olaiavelasco potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
AT gemagrau potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
AT luiscastano potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
AT federicadinolfo potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
AT carlaferreri potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
AT saraarranz potentialoferythrocytemembranelipidprofileasanovelinflammatorybiomarkertodistinguishmetabolicallyhealthyobesityinchildren
_version_ 1721512026512031744